Tuesday, October 24, 2023

09:30 am - 09:40 am EST
Welcoming Remarks

Eric Freed, Ph.D.

NCI-Frederick

09:40 am - 10:15 am EST
Cancer Immunotherapy with recombinant poliovirus

Matthias Gromeier, M.D.

Duke University School of Medicine

10:15 am - 10:50 am EST
CAR T-cell therapy for hematologic malignancies

Jennifer Brudno, M.D.

National Cancer Institute

10:50 am - 11:25 am EST
AAV-vectored expression of monoclonal antibodies for protection against infectious diseases

Sarah Wootton, BSc, Ph.D.

Ontario Veterinary College

11:25 am - 12:00 pm EST
Tuning antiviral immunity with gene-based vectors

Nancy Sullivan, ScD.

Boston University

12:00 pm - 01:20 pm EST
Lunch/Poster Session
01:20 pm - 01:55 pm EST
In vivo affinity maturation of engineered B cells for better vaccines and anti-viral antibodies

Michael Farzan, Ph.D.

Harvard University

01:55 pm - 02:30 pm EST
The unique immune biology of cytomegalovirus-based vaccines

Klaus Fruh, Ph.D.

Oregon Health and Sciences University

02:30 pm - 03:05 pm EST
Phage Therapy

Robert "Chip" Schooley, M.D.

UC San Diego

03:05 pm - 03:45 pm EST
Break/Poster Session
03:45 pm - 04:20 pm EST
The enemy within: Turning transposons from foes to friends

David Largaespada, Ph.D.

University of Minnesota

04:20 pm - 04:55 pm EST
Virus vs virus: Human endogenous retroviruses as antiviral restriction factors

John Coffin, Ph.D.

Tufts University

04:55 pm - 05:05 pm EST
Closing Remarks

Eric Freed, Ph.D.

NCI-Frederick